Summary
The $560 million company will stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs online in Europe and Asia.
Source: Australian Financial Review
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
